BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9389851)

  • 1. Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia.
    Quane KA; Ording H; Keating KE; Manning BM; Heine R; Bendixen D; Berg K; Krivosic-Horber R; Lehmann-Horn F; Fagerlund T; McCarthy TV
    Br J Anaesth; 1997 Sep; 79(3):332-7. PubMed ID: 9389851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
    Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
    Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees.
    Keating KE; Quane KA; Manning BM; Lehane M; Hartung E; Censier K; Urwyler A; Klausnitzer M; Muller CR; Heffron JJ
    Hum Mol Genet; 1994 Oct; 3(10):1855-8. PubMed ID: 7849712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
    Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
    Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
    Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG
    Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
    Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
    Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
    Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F
    Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
    Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
    Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a positive malignant hyperthermia (MH) disposition without the in vitro contracture test in families carrying the RYR1 Arg614Cys mutation.
    Rueffert H; Olthoff D; Deutrich C; Froster UG
    Clin Genet; 2001 Aug; 60(2):117-24. PubMed ID: 11553045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
    Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V
    J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
    Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
    Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred.
    Lynch PJ; Krivosic-Horber R; Reyford H; Monnier N; Quane K; Adnet P; Haudecoeur G; Krivosic I; McCarthy T; Lunardi J
    Anesthesiology; 1997 Mar; 86(3):620-6. PubMed ID: 9066328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype.
    Sambuughin N; McWilliams S; de Bantel A; Sivakumar K; Nelson TE
    Am J Hum Genet; 2001 Jul; 69(1):204-8. PubMed ID: 11389482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in a malignant hyperthermia Italian family.
    Fortunato G; Berruti R; Brancadoro V; Fattore M; Salvatore F; Carsana A
    Eur J Hum Genet; 2000 Feb; 8(2):149-52. PubMed ID: 10757649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases.
    Broman M; Gehrig A; Islander G; Bodelsson M; Ranklev-Twetman E; Rüffert H; Müller CR
    Br J Anaesth; 2009 May; 102(5):642-9. PubMed ID: 19346234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
    Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
    Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations.
    Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM
    Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
    Brandom BW; Bina S; Wong CA; Wallace T; Visoiu M; Isackson PJ; Vladutiu GD; Sambuughin N; Muldoon SM
    Anesth Analg; 2013 May; 116(5):1078-1086. PubMed ID: 23558838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.